<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04251234</url>
  </required_header>
  <id_info>
    <org_study_id>HUM00173528</org_study_id>
    <nct_id>NCT04251234</nct_id>
  </id_info>
  <brief_title>Light at Night Study</brief_title>
  <acronym>LAN</acronym>
  <official_title>Light at Night Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Michigan</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this mechanistic study is to examine light sensitivity (melatonin suppression)&#xD;
      in people with bipolar depression I, and compare it to healthy controls. This is not a&#xD;
      treatment study.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The bipolar disorder I and healthy control arms are recruited from the existing Heinz C.&#xD;
      Prechter Bipolar Research Program at the University of Michigan.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    COVID shutdown&#xD;
  </why_stopped>
  <start_date type="Actual">October 15, 2020</start_date>
  <completion_date type="Actual">August 4, 2021</completion_date>
  <primary_completion_date type="Actual">August 4, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>There is no masking. The dim light (&lt;1 lux) condition is first, followed by the room light (~30 lux) condition. Participants are aware of this condition order.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Melatonin levels</measure>
    <time_frame>Up to approximately 6 weeks</time_frame>
    <description>Melatonin will be reported as an average percentage of suppression in the ~30 lux condition as compared to &lt;1 lux</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">2</enrollment>
  <condition>Bipolar Disorder</condition>
  <condition>Light Sensitivity</condition>
  <arm_group>
    <arm_group_label>Healthy controls</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>No co-morbid medical or psychiatry diagnoses&#xD;
No family history of mental illness&#xD;
No current medication use&#xD;
Non-smoking</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bipolar I disorder</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Clinical diagnosis of Bipolar I disorder&#xD;
Can be (not required, not exclusionary) taking lithium and/or sodium valproate and/or antidepressants&#xD;
Can be (not required, not exclusionary) light smokers</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Light intensity, ~30 lux</intervention_name>
    <description>~30 lux compared to very dim light baseline condition &lt;1 lux</description>
    <arm_group_label>Bipolar I disorder</arm_group_label>
    <arm_group_label>Healthy controls</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Baseline light intensity, &lt;1 lux</intervention_name>
    <description>Very dim light condition</description>
    <arm_group_label>Bipolar I disorder</arm_group_label>
    <arm_group_label>Healthy controls</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  BMI 18-30 kg/m2&#xD;
&#xD;
          -  Appropriate sleep schedules according to study staff. Sleep schedule is self-reported&#xD;
             and confirmed through a sleep diary&#xD;
&#xD;
          -  Healthy eyes as ascertained by eye exam at University of Michigan Kellogg Eye Center&#xD;
&#xD;
          -  Willing and able to maintain stable sleep schedule during study.&#xD;
&#xD;
          -  Participants will be breathalyzed and undergo urine drugs screens at every lab visit&#xD;
&#xD;
          -  Acknowledge and understand that participants cannot drive themselves home after&#xD;
             certain lab visits. Note that the research team will provide a travel stipend of $10&#xD;
             per visit to offset potential rideshare/taxi costs&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Color blindness&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Helen Burgess, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Michigan</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>January 30, 2020</study_first_submitted>
  <study_first_submitted_qc>January 30, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 31, 2020</study_first_posted>
  <last_update_submitted>August 4, 2021</last_update_submitted>
  <last_update_submitted_qc>August 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Michigan</investigator_affiliation>
    <investigator_full_name>Helen Burgess</investigator_full_name>
    <investigator_title>Professor of Psychiatry</investigator_title>
  </responsible_party>
  <keyword>Circadian</keyword>
  <keyword>Light Intensity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Photophobia</mesh_term>
    <mesh_term>Bipolar Disorder</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

